Saurabh Vig

Saurabh Vig

Auto-generated profile, based on publicly available information

Saurabh Vig

Department of Onco-Anaesthesia and Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2021 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
SBSwati Bhan
Swati Bhan
SMSeema Mishra
Seema Mishra
NGNishkarsh Gupta
Nishkarsh Gupta
RGRakesh Garg
Rakesh Garg
SVSaurabh Vig
Saurabh Vig
SBSushma Bhatnagar
Sushma Bhatnagar
Breast cancer,modified radical mastectomy,serratus anterior plane block Introduction

1 January 2017 in Indian Journal of Palliative Care
Verified
Journal Article
Open access
PDF file
SBSushma Bhatnagar
Sushma Bhatnagar
KKKomal Kashyap
Komal Kashyap
SJSaurabh Joshi
Saurabh Joshi
SVSaurabh Vig
Saurabh Vig
VSVishwajeet Singh
Vishwajeet Singh
Aim of the Study: To study the effect of scrambler therapy on patients with chronic cancer pain. Materials and Methods: This is a prospective, observational study conducted on patients with chronic pain due to malignancy which is not responding to oral analgesics. A total of twenty patients were included in the study (ten males, ten females) with a visual analog scale score of >4 on oral analgesics. Patients aged 18–70 years with a life expectancy of >3 months having bony, neuropathic, or mixed type of pain were included in the study. A total of 12 sessions of scrambler therapy were planned, ten sessions on consecutive days and one session each on two follow-up visits after 1 week each. Each session lasted for 40 min. Pain relief and quality of life according to the World Health Organization Quality of Life were recorded as primary outcome variables. Results: All patients had good pain relief and improvement in all four domains of quality of life. Pain scores decreased significantly (P < 0.01) after each session and at each follow-up. Patients showed significant improvement in physical, psychological, social, and environmental health (P < 0.01) after the therapy. Conclusion: Scrambler therapy offers a promising role in the pain physician's armamentarium as an adjunct to pharmacological therapy for the treatment of chronic drug-resistant cancer pain; it may bring down analgesic drug requirements significantly and improve quality of life in cancer patients. Larger prospective, randomized multicenter studies are needed to validate the findings of the small pilot studies published in literature so far.

10 April 2022 in Cureus
Verified
Journal Article
Open access
PSPrashant Sirohiya
Prashant Sirohiya
SVSaurabh Vig
Saurabh Vig
KPKhushboo Pandey
Khushboo Pandey
JMJitendra K. Meena
Jitendra K. Meena
RSRam Singh
Ram Singh
SBSushma Bhatnagar
Sushma Bhatnagar
It has been observed that peripheral oxygen saturation (SpO2) measured by pulse oximeter is consistently lower than arterial oxygen saturation (SaO2) measured directly by blood gas analysis. In this study, we aimed to evaluate the correlation between SpO2 and SaO2, and SpO2 and partial pressure of oxygen (PaO2), and compare the SpO2/FiO2 (SF) and PaO2/FiO2 (PF) ratios in patients with coronavirus disease 2019 (COVID-19). In this observational study, SpO2 was recorded and arterial blood gas analysis was performed among 70 COVID-19 patients presenting on room air (FiO2 = 0.21). SaO2 and PaO2 were recorded from arterial blood gas analysis. The SF and PF ratios were then calculated. The strength of correlations between SpO2 and SaO2, and SpO2 and PaO2, were significant (p<0.001) and moderately positive [Pearson coefficient (r) = 0.68, 0.53]. SpO2 value (85%), i.e., SF ratio (404.7 or below), was the best estimate for mild ARDS (acute respiratory distress syndrome) [PF ratio (300 or below)] with a sensitivity of 80.6% and specificity of 53%. A pulse oximeter is a vital tool in the diagnosis and management of COVID-19. In our study, SpO2 was found to have a positive correlation with SaO2 and PaO2 with acceptable sensitivity but low specificity in estimating mild ARDS. Therefore, pulse oximetry can be used as a tool for the early diagnosis of mild COVID-19 ARDS as per the given considerations and clinical correlation.

17 July 2020 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Closed access
KPKhushboo Pandey
Khushboo Pandey
SVSaurabh Vig
Saurabh Vig
BRBrajesh Ratre
Brajesh Ratre
NGNishkarsh Gupta
Nishkarsh Gupta

31 December 2021 in Drug Discoveries & Therapeutics
Verified
Journal Article
Open access
PDF file
SPSaurav Sekhar Paul
Saurav Sekhar Paul
BLBhavesh Mohan Lal
Bhavesh Mohan Lal
ARAnimesh Ray
Animesh Ray
VMVed Prakash Meena
Ved Prakash Meena
RGRohit Kumar Garg
Rohit Kumar Garg
NWNaveet Wig
Naveet Wig
COVID-19 is associated with rarer extra-parenchymal manifestations, namely pneumothorax (PTX) and pneumomediastinum (PM) leading to complications and increased mortality. The study aims to describe the prevalence, risk factors for mortality, radiological characteristics and outcome of PTX/PM in patients admitted with COVID-19. This was a retrospective, single-centre, observational study in patients with confirmed COVID-19 presenting with non-iatrogenic PTX/PM from April 2020 to May 2021. Details pertaining to demographics, presentation, radiological characteristics, management and outcome were collected. Cases were classified into spontaneous and barotraumatic PTX/PM and a between-group comparison was performed using Chi-square and t-test. A total of 45 cases (mean age: 53.2 years, 82% males) out of 8,294 confirmed COVID-19 patients developed PTX/PM, the calculated incidence being 0.54%. 29 cases had spontaneous PTX/PM and the remaining 17 cases were attributed to barotrauma. The most common comorbidities were diabetes-mellitus (65.3%) and hypertension (42.3%). The majority of the cases had large PTX (62.1%) with tension in 8 cases (27.5%). There were predominant right-sided pneumothoraces and five were diagnosed with bronchopleural fistula. 37.7% of cases had associated subcutaneous emphysema. The median duration of PTX/PM from symptom onset was delayed at 22.5 and 17.6 days respectively. The mean CT severity score (CTSS) was 20.5 (± 4.9) with fibrosis (53.8%), bronchiectatic changes (50%) and cystic-cavitary changes (23%). There was no statistically significant difference between the spontaneous and barotrauma cohort. 71% of cases died and the majority belonged to the barotrauma cohort. It is imperative to consider the possibility of PTX/PM in patients having COVID-19, especially in those with deterioration in the disease course, both in spontaneously breathing and mechanically ventilated patients. These patients may also have a high incidence of death, reflecting the gravity of COVID-19.

1 August 2022 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Open access
NGNishkarsh Gupta
Nishkarsh Gupta
RSRiniki Sarma
Riniki Sarma
SVSaurabh Vig
Saurabh Vig
VKVinod Kumar
Vinod Kumar
AGAnju Gupta
Anju Gupta
SBSushma Bhatnagar
Sushma Bhatnagar
Aerosol,airway management,COVID-19,laryngoscopes,personal protective equipment,videolaryngoscopes